International Isotopes completes $4M asset sale to Pharmalogic; extends Series C Preferred maturity

RADNOSTIX INC

Completed sale of manufacturing equipment and sublease to Pharmalogic Idaho for $4.0M cash on Feb 18, 2022.
Series C Preferred Stock maturity extended by ~1 year to February 28, 2023, approved by majority of holders.
Certificate of Amendment filed with Texas Secretary of State on Feb 16, 2022 to reflect the extension.
The assets sold were acquired via a prior manufacturing and supply agreement termination.

item 2.01 item 1.01 item 3.03 item 5.03 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.